Stock listing
Hualan Biological Engineering Inc. Class A
Selected listing: 002007 · SZSE · CNY · CN
Hualan Biological Engineering Inc. Class A (Shenzhen:002007), Health Technology. Latest release Apr 27, 2026: Hualan Biological Engineering: Revenue…
- Ticker
- Shenzhen:002007
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Shenzhen
- Currency
- CNY
About Hualan Biological Engineering Inc. Class A
The company specializes in the development and production of biological products, contributing to the healthcare sector. Hualan is recognized for its commitment to innovation and quality in the biotechnology industry.
Latest news from Hualan Biological Engineering Inc. Class A
Hualan Biological Engineering: Revenue and profit fell sharply year-over-year amid regulatory and tax changes
April 26, 2026
Hualan Biological Engineering: 2025 revenue rose 4.93% to ¥4.60B, net profit fell 13.55% to ¥940M, dividend payout 97%
March 27, 2026
Hualan Biological Engineering: Q3 2025 saw a 14% revenue drop and 44.45% net profit decline year-over-year
October 30, 2025
Hualan Biological Engineering: Net profit rose 17.2% year-over-year on strong blood product sales and higher R&D investment
August 28, 2025
Hualan Biological Engineering: Revenue and net profit rose, but cash flow weakened amid higher investment outflows
April 28, 2025
Research Hualan Biological Engineering Inc. Class A
Hualan Biological Engineering Inc. Class A company profile
View the public company page for Hualan Biological Engineering Inc. Class A on 6ix.
Hualan Biological Engineering Inc. Class A news
Read company news and market updates connected to Hualan Biological Engineering Inc. Class A.
Hualan Biological Engineering Inc. Class A investor events
Find investor webinars, events, and replay context for Hualan Biological Engineering Inc. Class A.